Prime Medicine Stock Quote PRME - Stock Price, News, Charts, Message Board, Trades

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Premium

Current Price

2.76

Bid

2.75

Ask

2.76

Volume

137,854

2.69 Day's Range 2.76

2.56 52 Week Range 9.80

Market Cap

362.004M

Previous Close

2.76

Open

2.74

Last Trade

2.7566

Last Trade Time

10:04:51

Financial Volume

$ 377,114

VWAP

2.7356

Average Volume (3m)

1,200,930

Shares Outstanding

131,160,842

Dividend Yield

PE Ratio

-1.83

Earnings Per Share (EPS)

-1.51

Revenue

Net Profit

-198.13M

Prime Medicine Inc is a biotechnology company committed to delivering genetic therapies to address diseases by deploying gene editing technology, Prime Editing. The Prime Editing technology is a next-generation technology that can search and replace to restore normal genetic function in the genome a... Prime Medicine Inc is a biotechnology company committed to delivering genetic therapies to address diseases by deploying gene editing technology, Prime Editing. The Prime Editing technology is a next-generation technology that can search and replace to restore normal genetic function in the genome and can treat a wide spectrum of diseases with high unmet medical needs. Show more

Sector

Biological Pds,ex Diagnstics

Industry

Biological Pds,ex Diagnstics

Website

www.primemedicine.com

Headquarters

Wilmington, Delaware, USA

Founded

Prime Medicine Inc is listed in the Biological Pds,ex Diagnstics sector of the NASDAQ with ticker PRME. The last closing price for Prime Medicine was $2.76. Over the last year, Prime Medicine shares have traded in a share price range of $ 2.56 to $ 9.80.

Prime Medicine currently has 131,160,842 shares outstanding. The market capitalization of Prime Medicine is $362 million. Prime Medicine has a price to earnings ratio (PE ratio) of -1.83.

Form EFFECT - Notice of Effectiveness

Form S-3 - Registration statement under Securities Act of 1933

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form 8-K - Current report

Prime Medicine Reports Third Quarter 2024 Financial Results and Provides Business Updates

-- Presented initial in vivo data for universal liver-targeted LNP and Wilson’s Disease program at ESGCT; initiated IND-enabling activities for Wilson’s Disease program in 4Q 2024 and remains on...

Prime Medicine to Participate in Upcoming Investor Conferences

CAMBRIDGE, Mass., Nov. 06, 2024 (GLOBE NEWSWIRE) -- Prime Medicine, Inc. (Nasdaq: PRME), a biotechnology company committed to delivering a new class of differentiated one-time curative genetic...

Form 8-K - Current report

Prime Medicine Presents In Vivo Proof-of-Concept Data Highlighting Interim Preclinical Advances in its Wilson’s Disease Program and the Broad Potential of its Universal Liver-Targeted LNP at ESGCT 31st Annual Congress

Delivery of Prime Editors with a proprietary, universal liver-targeted LNP was well tolerated, with no safety concerns or detectable off-target edits observed across multiple preclinical studies...

Prime Medicine to Highlight New Preclinical Data, Including In Vivo Data in Wilson’s Disease, at Upcoming Scientific Meetings

-- On-track to initiate IND-enabling activities for Wilson’s Disease program in 4Q 2024, with IND or CTA filing expected in 1H 2026 -- CAMBRIDGE, Mass., Oct. 15, 2024 (GLOBE NEWSWIRE) -- Prime...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0.02	0.729927007299	2.74	3.05	2.56	1402427	2.83826626	CS
4	-0.56	-16.8674698795	3.32	3.515	2.56	1264526	3.02182771	CS
12	-0.67	-19.5335276968	3.43	4.71	2.56	1200930	3.52266638	CS
26	-3.08	-52.7397260274	5.84	6.75	2.56	1224523	3.93054229	CS
52	-6.66	-70.7006369427	9.42	9.8	2.56	992354	5.02525689	CS
156	-16.21	-85.45071165	18.97	21.7301	2.56	648628	7.2878939	CS
260	-16.21	-85.45071165	18.97	21.7301	2.56	648628	7.2878939	CS

PRME - Frequently Asked Questions (FAQ)

What is the current Prime Medicine share price?

The current share price of Prime Medicine is $ 2.76

How many Prime Medicine shares are in issue?

Prime Medicine has 131,160,842 shares in issue

What is the market cap of Prime Medicine?

The market capitalisation of Prime Medicine is USD 362M

What is the 1 year trading range for Prime Medicine share price?

Prime Medicine has traded in the range of $ 2.56 to $ 9.80 during the past year

What is the PE ratio of Prime Medicine?

The price to earnings ratio of Prime Medicine is -1.83

What is the reporting currency for Prime Medicine?

Prime Medicine reports financial results in USD

What is the latest annual profit for Prime Medicine?

The latest annual profit of Prime Medicine is USD -198.13M

What is the registered address of Prime Medicine?

The registered address for Prime Medicine is CORPORATION TRUST CENTER, 1209 ORANGE ST, WILMINGTON, DELAWARE, 19801

What is the Prime Medicine website address?

The website address for Prime Medicine is www.primemedicine.com

Which industry sector does Prime Medicine operate in?

Prime Medicine operates in the BIOLOGICAL PDS,EX DIAGNSTICS sector

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
MGIHMillennium Group International Holdings Ltd	$ 4.88 (218.95%)	52.83M
SPRCSciSparc Ltd	$ 0.553 (150.00%)	165.45M
SKKSKK Holdings Limited	$ 1.6605 (121.99%)	4.38M
ZCARZoomcar Holdings Inc	$ 2.56 (79.02%)	42.58M
COEPCoeptis Therapeutics Holdings Inc	$ 0.2298 (61.83%)	136.06M
NEUPNeuphoria Therapeutics Inc	$ 4.1193 (-37.87%)	282.54k
BAOSBaosheng Media Group Holdings Ltd	$ 4.7529 (-33.06%)	747.87k
HOURHour Loop Inc	$ 3.05 (-30.68%)	3.76M
SVRESaverOne 2014 Ltd	$ 1.0593 (-29.85%)	662.86k
GTIGraphjet Technology	$ 0.44 (-27.87%)	7.63M
SPRCSciSparc Ltd	$ 0.5503 (148.78%)	165.46M
COEPCoeptis Therapeutics Holdings Inc	$ 0.228 (60.56%)	136.07M
SMXSMX Security Matters Public Company	$ 0.294 (34.86%)	84.12M
RGTIRigetti Computing Inc	$ 13.1948 (16.25%)	55.7M
MGIHMillennium Group International Holdings Ltd	$ 4.88 (218.95%)	52.83M